Biosimilar Innovation

UCI Law's Annual Intellectual Property Law Conference

Friday, February 8, 2019
8:30 a.m.–5:00 p.m.
UC Irvine School of Law, MPAA 420 (Directions)


Livestream > 

Biosimilar medical products offer the promise of enhanced medical therapies at sustainable pricing. However, the scientific and economic challenges associated with biosimilars threaten to impede the promise of such medical advances. New incentive strategies are needed to advance development in this area. 

To address such challenges, speakers at this conference will explore the legal and regulatory frameworks needed to encourage innovative development and distribution of biosimilar products.

Confirmed participants include:

Schedule of Events (PDF)

Abstracts (PDF)

This event is approved for 5.5 hours of Continuing Legal Education Credit by the State Bar of California. UC Irvine School of Law is a State Bar-approved MCLE provider. 

For more event details or to request reasonable accommodations for a disability, please email